Results 241 to 250 of about 38,429 (312)

Sclerosing diseases of the skin

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Sclerosing skin diseases comprise a group of distinct dermatological conditions characterized by fibrotic changes that may severely impair patients’ quality of life. These conditions often present with cutaneous manifestations and, in some cases, may extend to extracutaneous tissues, potentially resulting in significant morbidity and mortality.
Yasamin Kalantari   +4 more
wiley   +1 more source

Early detection of infants with neurodevelopmental concerns indicative of cerebral palsy in a lower middle‐income country (India)

open access: yesDevelopmental Medicine &Child Neurology, EarlyView.
In this prospective sub‐study testing the predictive validity of General Movements Assessment (GMA) and/or Hammersmith Infant Neurological Examination (HINE), 785 infants with birth/infant‐detectable risk factors, aged 12 to 40 weeks corrected age were recruited. GMA and HINE were reliable and accurate tools for screening high‐risk populations in India,
Katherine A. Benfer   +13 more
wiley   +1 more source

Intentional coronary revascularization versus conservative therapy in patients after peripheral artery revascularization due to critical limb ischemia: the INCORPORATE trial. [PDF]

open access: yesClin Res Cardiol
Toth GG   +14 more
europepmc   +1 more source

Modeling cerebral palsy in animals

open access: yesDevelopmental Medicine &Child Neurology, EarlyView.
Abstract Advancements in the treatment of cerebral palsy depend on animal research. Yet, most animal models have not been fully evaluated for spasticity and dystonia using clinically relevant measures of altered tone or movement patterns, which form the basis for diagnosing people with the condition.
Katharina A. Quinlan   +8 more
wiley   +1 more source

2. Angiogenic Therapy for Critical Limb Ischemia

open access: bronze, 2008
Yusuke Nakagawa   +4 more
openalex   +2 more sources

Diffusion imaging shows microstructural alterations in untreated, non‐lesional patients already after a first unprovoked seizure

open access: yesEpilepsia, Volume 66, Issue 3, Page 833-846, March 2025.
Abstract Objective Patients with newly diagnosed epilepsy exhibit brain white matter (WM) abnormalities, but the temporal dynamics of these are unknown. The literature suggests these alterations might be present before diagnosis. This study investigates WM microstructural integrity using diffusion imaging in non‐lesional (NL), interictal epileptiform ...
Marysol Segovia‐Oropeza   +3 more
wiley   +1 more source

Cannabidiol attenuates epileptic phenotype and increases survival in a mouse model of developmental and epileptic encephalopathy type 1

open access: yesEpilepsia, EarlyView.
Abstract Objective Developmental and epileptic encephalopathy type 1 (DEE1) is a rare drug‐resistant pediatric epilepsy caused by trinucleotide repeat expansions in the X‐linked ARX gene, leading to elongation of the first polyalanine tract. It presents with early onset tonic seizures or spasms, developmental and cognition delay, and high risk of ...
Lucia Verrillo   +9 more
wiley   +1 more source

WONOEP XVII appraisal: Targeting network excitability beyond the synapse ‐Neurotransmitter, ionic, and electro ‐diffusions

open access: yesEpilepsia, EarlyView.
Abstract Epilepsy affects approximately 1% of the population worldwide, and although medications are effective in the majority of cases, seizures persist in approximately 30% of patients. Despite the effort to develop new antiseizure drugs, the rate of pharmacoresistance in patients has not diminished over the past 3 decades. There is thus a real unmet
Vincent Magloire   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy